Coffee Consumption and Metabolic Health

Abstract Background: Coffee is among the most widely consumed beverages globally, and its relationship with metabolic health has been the subject of extensive but sometimes contradictory research. While early epidemiological concerns about cancer risk have largely been resolved, the specific mechanisms through which coffee's bioactive compounds influence metabolic outcomes remain incompletely understood, particularly when accounting for variation in roasting profiles and preparation methods. Methods: This review synthesizes evidence from observational studies, randomized controlled trials, and mechanistic investigations published between 1991 and 2026 to examine how coffee consumption affects metabolic health, with attention to cardiovascular protection, type 2 diabetes risk reduction, glucose and lipid metabolism, hepatic health and bone health. Results: Moderate coffee consumption, approximately three to four standard cups per day, is consistently associated with favorable cardiometabolic outcomes, particularly when coffee is filtered. Paper filtration retains many phenolic compounds while substantially reducing diterpenes, whereas unfiltered preparations deliver higher cafestol and kahweol exposure and can elevate LDL cholesterol. Roast level further alters chlorogenic acid, melanoidin, and trigonelline concentrations, with medium roasts retaining a more favorable balance of chlorogenic acids and trigonelline than darker roasts, although human outcome data comparing roast levels remain limited. Conclusion: Evidence supports a protective association between moderate coffee intake and metabolic health, but the magnitude and direction of effects depend on roast type, brewing method, and caffeine-metabolism phenotype. Because clinical trials rarely control for roast profile and brewing method together, future research should use standardized coffee preparations before dietary guidance can move beyond generic cup-per-day recommendations. Keywords: Coffee, caffeine, metabolic health, antioxidants, epidemiology.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-03
DOI
https://doi.org/10.5281/zenodo.23812397
Primary Topic
Coffee research and impacts
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
preprint

Coffee Consumption and Metabolic Health

Fahmida Jahan
Zenodo (CERN European Organization for Nuclear Research)
Coffee research and impacts
preprint

Coffee Consumption and Metabolic Health

Fahmida Jahan
preprint en

Abstract

Abstract Background: Coffee is among the most widely consumed beverages globally, and its relationship with metabolic health has been the subject of extensive but sometimes contradictory research. While early epidemiological concerns about cancer risk have largely been resolved, the specific mechanisms through which coffee's bioactive compounds influence metabolic outcomes remain incompletely understood, particularly when accounting for variation in roasting profiles and preparation methods. Methods: This review synthesizes evidence from observational studies, randomized controlled trials, and mechanistic investigations published between 1991 and 2026 to examine how coffee consumption affects metabolic health, with attention to cardiovascular protection, type 2 diabetes risk reduction, glucose and lipid metabolism, hepatic health and bone health. Results: Moderate coffee consumption, approximately three to four standard cups per day, is consistently associated with favorable cardiometabolic outcomes, particularly when coffee is filtered. Paper filtration retains many phenolic compounds while substantially reducing diterpenes, whereas unfiltered preparations deliver higher cafestol and kahweol exposure and can elevate LDL cholesterol. Roast level further alters chlorogenic acid, melanoidin, and trigonelline concentrations, with medium roasts retaining a more favorable balance of chlorogenic acids and trigonelline than darker roasts, although human outcome data comparing roast levels remain limited. Conclusion: Evidence supports a protective association between moderate coffee intake and metabolic health, but the magnitude and direction of effects depend on roast type, brewing method, and caffeine-metabolism phenotype. Because clinical trials rarely control for roast profile and brewing method together, future research should use standardized coffee preparations before dietary guidance can move beyond generic cup-per-day recommendations. Keywords: Coffee, caffeine, metabolic health, antioxidants, epidemiology.

Zenodo (CERN European Organization for Nuclear Research)
Coffee research and impacts
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon